Effectiveness and Tolerability of Subcutaneous Tocilizumab in Rheumatoid Arthritis Patients Switched From Intravenous Tocilizumab: Results From the Extension Period of the Musashi Study

被引：0
|
作者：
Ogata, Atsushi [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1295
引用
收藏
页码：S555 / S555
页数：1
相关论文
共 50 条
  • [1] Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis
    Emery, Paul
    Rondon, Juan
    Parrino, Janie
    Lin, Yong
    Pena-Rossi, Claudia
    van Hoogstraten, Hubert
    Graham, Neil M. H.
    Liu, Nancy
    Paccaly, Anne
    Wu, Richard
    Spindler, Alberto
    RHEUMATOLOGY, 2019, 58 (05) : 849 - 858
  • [2] Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study
    Jean Darloy
    Nicolas Segaud
    Jean-Hugues Salmon
    Jean-Paul Eschard
    Vincent Goëb
    Xavier Deprez
    Marie-Hélène Guyot
    Eric Houvenagel
    Nicolas Lecuyer
    Laurent Marguerie
    Samuel Gally
    David Pau
    Isabelle Idier
    Guy Baudens
    René-Marc Flipo
    Rheumatology and Therapy, 2019, 6 : 61 - 75
  • [3] Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study
    Darloy, Jean
    Segaud, Nicolas
    Salmon, Jean-Hugues
    Eschard, Jean-Paul
    Goeb, Vincent
    Deprez, Xavier
    Guyot, Marie-Helene
    Houvenagel, Eric
    Lecuyer, Nicolas
    Marguerie, Laurent
    Gally, Samuel
    Pau, David
    Idier, Isabelle
    Baudens, Guy
    Flipo, Rene-Marc
    RHEUMATOLOGY AND THERAPY, 2019, 6 (01) : 61 - 75
  • [4] Evaluation of switching from intravenous to subcutaneous formulation of tocilizumab in patients with rheumatoid arthritis
    Iwamoto, Naoki
    Fukui, Shoichi
    Umeda, Masataka
    Nishino, Ayako
    Nakashima, Yoshikazu
    Suzuki, Takahisa
    Horai, Yoshiro
    Nonaka, Fumiaki
    Okada, Akitomo
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Fujikawa, Keita
    Aramaki, Toshiyuki
    Ichinose, Kunihiro
    Hirai, Yasuko
    Tamai, Mami
    Nakamura, Hideki
    Terada, Kaoru
    Nakashima, Munetoshi
    Mizokami, Akinari
    Origuchi, Tomoki
    Eguchi, Katsumi
    Ueki, Yukitaka
    Kawakami, Atsushi
    MODERN RHEUMATOLOGY, 2016, 26 (05) : 662 - 666
  • [5] Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study
    Nuray Aktay Ayaz
    Şerife Gül Karadağ
    Rahime Koç
    Fatma Gül Demirkan
    Figen Çakmak
    Hafize Emine Sönmez
    Rheumatology International, 2020, 40 : 1111 - 1116
  • [6] Patient satisfaction and clinical effectiveness of switching from intravenous tocilizumab to subcutaneous tocilizumab in patients with juvenile idiopathic arthritis: an observational study
    Ayaz, Nuray Aktay
    Karadag, Serife Gul
    Koc, Rahime
    Demirkan, Fatma Gul
    Cakmak, Figen
    Sonmez, Hafize Emine
    RHEUMATOLOGY INTERNATIONAL, 2020, 40 (07) : 1111 - 1116
  • [7] Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis
    Ogata, Atsushi
    Atsumi, Tatsuya
    Fukuda, Takaaki
    Hirabayashi, Yasuhiko
    Inaba, Masaaki
    Ishiguro, Naoki
    Kai, Motokazu
    Kawabata, Daisuke
    Kida, Daihei
    Kohsaka, Hitoshi
    Matsumura, Ryutaro
    Minota, Seiji
    Mukai, Masaya
    Sumida, Takayuki
    Takasugi, Kiyoshi
    Tamaki, Shigenori
    Takeuchi, Tsutomu
    Ueda, Atsuhisa
    Yamamoto, Kazuhiko
    Yamanaka, Hisashi
    Yoshifuji, Hajime
    Nomura, Akira
    ARTHRITIS CARE & RESEARCH, 2015, 67 (10) : 1354 - 1362
  • [8] Flare After Switching from Intravenous Tocilizumab to Subcutaneous Formulation in Patients with Rheumatoid Arthritis
    Ahn, Soo Min
    Oh, Ji Seon
    Heo, Hyun Mi
    Hong, Seokchan
    Lee, Chang-Keun
    Yoo, Bin
    Kim, Yong-Gil
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1728 - 1730
  • [9] SAFETY, TOLERABILITY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB ADMINISTERED AS MONOTHERAPY OR IN COMBINATION WITH CSDMARDS IN RHEUMATOID ARTHRITIS: RESULTS FROM THE OSCAR STUDY
    Safy, M.
    De Hair, M. J.
    Borm, M. E.
    Kok, M. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 324 - 325
  • [10] Effectiveness of Tocilizumab after Switching from Intravenous to Subcutaneous Formulation in Patients with Rheumatoid Arthritis: A Single-Centre Experience
    Stojanovic, Sonja
    Stamenkovic, Bojana
    Nedovic, Jovan
    Aleksic, Ivana
    Cvetkovic, Jovana
    ACTA FACULTATIS MEDICAE NAISSENSIS, 2021, 38 (03) : 247 - 256
12345